BBB National Programs Decision Summaries

The National Advertising Division has referred advertising claims made by The a2 Milk Company (a2MC) for its a2 Milk product to the Federal Trade Commission (FTC) for further review, after the advertiser declined to participate in a review of its advertising claims, including claims that its product is “Easier on digestion” and “May help some avoid discomfort.”

The National Advertising Division has referred advertising claims made by LG Electronics USA, Inc., to the Federal Trade Commission (FTC) for further review, following LG’s decision against complying with NAD recommendations regarding claims to “perfect black” and “infinite contrast.”

The National Advertising Division has recommended that AT&T Services Inc., modify or discontinue certain claims made as part of the company’s “More for Your Thing,” advertising campaign. AT&T said it will appeal those adverse findings to the National Advertising Review Board (NARB).

The National Advertising Division has recommended that Comcast Cable Communications, LLC, discontinue the implied claim, featured in a broadcast advertisement, that DirecTV is highly unreliable in bad weather and modify its advertising to avoid conveying the message that DirecTV offers no free shows or movies on the go.

The National Advertising Division has recommended that that Philips Oral Healthcare, Inc., modify certain advertising claims for the company’s Sonicare DiamondClean toothbrush, following a challenge by The Procter & Gamble Company, maker of Oral-B oral health products.

The National Advertising Division has referred advertising claims made by Cross Brands Manufacturing, LLC, for the company’s Sea & Ski brand sun care products, to the Federal Trade Commission (FTC) and Food and Drug Administration (FDA) after the company declined to state whether it would comply with NAD’s recommendations to discontinue certain advertising claims.

The National Advertising Division has referred to the Food and Drug Administration (FDA) and Federal Trade Commission (FTC) advertising claims made by Aubio Life Sciences for its Cold Sore Treatment Gel that communicate the product provides relief at the “first sign” of a cold sore or during the “tingling” phase of an outbreak.

The National Advertising Division has recommended that Chattem, Inc., manufacturer of the ACT brand of oral care products, discontinue certain advertising claims for the company’s ACT “Dry Mouth” products, including claims that ACT Dry Mouth Mouthwash “provides immediate, long-lasting relief” and “soothes dry mouth” and that ACT Dry Mouth Lozenges are uniquely formulated to stimulate saliva flow and soothe and moisturize dry mouth. Chattem said it will appeal those findings.

The National Advertising Division has recommended that Telebrands, Corp., discontinue certain advertising claims for the company’s Atomic Beam flashlights, including claims that they are “40 times brighter” and more durable than ordinary flashlights and are equipped with features that ordinary flashlights do not provide.

The National Advertising Division has recommended that Chattem, Inc., discontinue claims that the company’s Xyzal Allergy 24 HR product works “Twice as fast as Claritin” and provides “relief that starts at hour 1 instead of hour 2.”